A Bioinformatic Algorithm based on Pulmonary Endoarterial Biopsy for Targeted Pulmonary Arterial Hypertension Therapy

Area of Science:

• Cardiovascular Medicine
• Pharmacogenomics
• Bioinformatics

Background:

• Pulmonary arterial hypertension (PAH) treatment is complex due to disease heterogeneity.
• Gene expression analysis may guide optimal medication selection for PAH patients.
• A bioinformatics approach can rank antihypertensive agents based on genetic data.

Purpose of the Study:

• To develop a bioinformatics method for ranking PAH medications.
• To utilize gene expression data from animal models for ranking therapeutic agents.
• To identify potential optimal medication regimens for PAH.

Main Methods:

• A chronic PAH model was established in swine.
• Percutaneous endoarterial biopsies were obtained from pulmonary arteries.
• RNA microarray analysis and literature review were used to rank medications.

Main Results:

• A method was developed to rank PAH medications based on gene expression.
• The ranking was performed at multiple time points post-modeling.
• A theoretical optimal three-medication regimen was identified.

Conclusions:

• A novel paradigm for PAH therapy involves endoarterial biopsy and molecular analysis.
• Tailored pharmacological therapy based on genetic profiles is proposed.
• This approach may improve PAH treatment strategies.